Mesoblast is a privately listed medical company that specialises in stem cell research. They have invented cutting edge technology that does not see the patient pop a pill. Its technologies are saving lives, but are struggling to get FDA approval due to the experimental nature of the drugs design. How will the American market (patient / medical consumer) and the FDA cope with a medicine that doesn't come in a pill form. Pills are socially acceptable in medicine but stem cells are questionable. While your thinking about that debate, another one rages in the background too....making money from medicine. Investors can make serious money from the misfortune of illness, at the same time lives are saved and lives are lost via FDA approving drugs that are possibly unsafe. Here is a investor video so you can make your mind up about a chart and a company that is saving lives, but struggling to get approval.
- Forums
- ASX - By Stock
- MSB
- Who will win
Who will win
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.46 |
Change
0.065(4.66%) |
Mkt cap ! $1.667B |
Open | High | Low | Value | Volume |
$1.41 | $1.50 | $1.40 | $5.699M | 3.943M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 122380 | $1.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.46 | 11015 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 119380 | 1.455 |
7 | 75073 | 1.450 |
5 | 55801 | 1.445 |
2 | 15656 | 1.440 |
2 | 37476 | 1.435 |
Price($) | Vol. | No. |
---|---|---|
1.460 | 11015 | 2 |
1.465 | 14833 | 2 |
1.470 | 49768 | 5 |
1.475 | 66248 | 3 |
1.480 | 37374 | 4 |
Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
3DA
AMAERO INTERNATIONAL LTD
Hank Holland, Executive Chairman and CEO
Hank Holland
Executive Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online